| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/02/2009 | US20090088389 Novel x-conotoxin peptides (-ii) |
| 04/02/2009 | US20090088388 Peptides for Use In Treating Obesity |
| 04/02/2009 | US20090088387 Composition for long-acting peptide analogs |
| 04/02/2009 | US20090088386 AMYLOID ß FIBRILLOGENESIS-INHIBITING PEPTIDE |
| 04/02/2009 | US20090088385 immunoglobulins; fibronectins; drug screening |
| 04/02/2009 | US20090088384 Therapeutic Fibrin-Derived Peptides And Uses Thereof |
| 04/02/2009 | US20090088383 Gh secretagogues and uses thereof |
| 04/02/2009 | US20090088382 Use of the cathelicidin LL-37 and derivatives therof for wound healing |
| 04/02/2009 | US20090088381 Compositions containing anti-hiv peptides and methods for use |
| 04/02/2009 | US20090088380 Ghrh analogs and therapeutic uses thereof |
| 04/02/2009 | US20090088379 Reconstituted surfactants having improved properties |
| 04/02/2009 | US20090088378 Long lasting inhibitors of viral infection |
| 04/02/2009 | US20090088377 Cysteic acid derivatives of anti-viral peptides |
| 04/02/2009 | US20090088376 Dendrimer based compositions and methods of using the same |
| 04/02/2009 | US20090088375 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 04/02/2009 | US20090088374 Novel use |
| 04/02/2009 | US20090088373 Use of compositions to enhance innate immune response |
| 04/02/2009 | US20090088372 Novel Bioconjugates As Therapeutic Agent and Synthesis Thereof |
| 04/02/2009 | US20090088371 Combination therapy with syk kinase inhibitor |
| 04/02/2009 | US20090088370 Method for Improved Isolation of Recombinantly Produced Proteins |
| 04/02/2009 | US20090088369 Glp-1 and methods for treating diabetes |
| 04/02/2009 | US20090088368 Compositions comprising them as ppar modulators |
| 04/02/2009 | US20090088367 Treatment of Insulin Resistance/Metabolic Syndrome to Alleviate the Risks of Dementia |
| 04/02/2009 | US20090088366 Nitrosated and nitrosylated prostaglandins, compositions and methods of use |
| 04/02/2009 | US20090088365 Biosynthetic Polypeptide Fusion Inhibitors |
| 04/02/2009 | US20090088364 Pharmaceutical composition useful for the treatment of invasive pulmonary aspergillosis |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087852 Mammalian selenoprotein differentially expressed in tumor cells |
| 04/02/2009 | US20090087836 Cytokines; fab fragments; fv fragments; monoclonal antibodies |
| 04/02/2009 | US20090087503 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 04/02/2009 | US20090087495 Food for Improving Motor Function |
| 04/02/2009 | US20090087494 Methods and Compositions for Targeted Delivery of Therapeutic Agents |
| 04/02/2009 | US20090087484 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/02/2009 | US20090087481 Using mixture comprising colony stimulating factor, interleukin-5 and/or a mimetic as therapeutic tool in treatment of nervous system disorders |
| 04/02/2009 | US20090087479 Orally bioavailable lipid-based constructs |
| 04/02/2009 | US20090087476 Pure polypeptide of sequence Tyr-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu; controlled release and liposome formulations |
| 04/02/2009 | US20090087474 Therapeutic use of growth factors,nsg29 and nsg31 |
| 04/02/2009 | US20090087473 Osteoinductive bone graft material and manufacturing method |
| 04/02/2009 | US20090087472 Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery |
| 04/02/2009 | US20090087469 Alginate-based nanofibers and related scaffolds |
| 04/02/2009 | US20090087459 Methods for treating eye disorders |
| 04/02/2009 | US20090087458 Activatable recombinant neurotoxins |
| 04/02/2009 | US20090087449 Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus |
| 04/02/2009 | US20090087445 Method for the Redox Potential-Dependent Detection of Target Molecules by Interacting Polypeptides |
| 04/02/2009 | US20090087437 Methods and compositions relating to the regulation of apoptosis by muc1 and bh3-containing proapoptotic proteins |
| 04/02/2009 | US20090087435 Isolated Chimeric Proteins Of Modified Lumazine Synthase |
| 04/02/2009 | US20090087433 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/02/2009 | US20090087431 Methods of treating bone disorders with modulators of axl |
| 04/02/2009 | US20090087428 Anti-fc-gamma riib receptor antibody and uses therefor |
| 04/02/2009 | US20090087424 Modulating Retinal Pigmented Epithelium Permeaion By Inhibiting Or Activating VEGFR-1 |
| 04/02/2009 | US20090087422 Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same |
| 04/02/2009 | US20090087421 Novel Recombinant Staphylokinase Derivatives and the Preparations and Applications thereof |
| 04/02/2009 | US20090087417 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/02/2009 | US20090087416 novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, vectors containing the nucleic acid molecules, and cells containing the vectors |
| 04/02/2009 | US20090087415 Treatment of cardiovascular disorders using the cell differentiation signaling protein Nell1 |
| 04/02/2009 | US20090087412 Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression |
| 04/02/2009 | US20090087411 Long-acting interferons and derivatives thereof and methods thereof |
| 04/02/2009 | US20090087410 Treatment of hypersensitivity |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | US20090087408 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 04/02/2009 | US20090087407 Methods for the treatment of scleroderma using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| 04/02/2009 | US20090087406 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof |
| 04/02/2009 | US20090087405 Use of Lck inhibitors for treatment of immunologic diseases |
| 04/02/2009 | US20090087404 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 04/02/2009 | US20090087403 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 04/02/2009 | US20090087388 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 04/02/2009 | US20090087375 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/02/2009 | CA2700985A1 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 04/02/2009 | CA2700925A1 Methods and compositions for modulating bcl-2 family polypeptides |
| 04/02/2009 | CA2700670A1 Prevention of allergy at weaning |
| 04/02/2009 | CA2700618A1 Inhibition of dendritic cell-driven regulatory t cell activation and potentiation of tumor antigen-specific t cell responses by interleukin-15 and map kinase inhibitor |
| 04/02/2009 | CA2700536A1 Cyclic undecapeptides and derivatives as multiple sclerosis therapies |
| 04/02/2009 | CA2700534A1 Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin |
| 04/02/2009 | CA2700391A1 Designed armadillo repeat proteins |
| 04/02/2009 | CA2700383A1 Urea-containing peptides as inhibitors of viral replication |
| 04/02/2009 | CA2699244A1 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 04/02/2009 | CA2699241A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699177A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699170A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699154A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699153A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699101A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699100A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699077A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699073A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699069A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699068A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699065A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699055A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699054A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699052A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699049A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699047A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699039A1 Use of bpp-b as a therapeutic agent |
| 04/02/2009 | CA2699035A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent |
| 04/02/2009 | CA2699000A1 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide gly-arg-gly-asp-asn-pro-oh as a therapeutic agent |
| 04/02/2009 | CA2698775A1 Big gastrin i as a therapeutic agent |
| 04/02/2009 | CA2698772A1 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 04/02/2009 | CA2698768A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698764A1 Use of a peptide as a therapeutic agent |